INTERSTITIAL CYSTITIS DRUGS MARKET ANALYSIS

Interstitial Cystitis Drugs Market, By Drug Class (Non-steroidal Anti-inflammatory Drugs, Tricyclic Antidepressants, Pentosan Polysulfate Sodium (Elmiron), Dimethyl Sulfoxide (DMSO), Others (Anti-histamines, etc.)), By Type (Non-ulcerative, Ulcerative), By Route of Administration (Oral, Intravesical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

Published In : Oct 2023
Code : CMI4488
Pages :142
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global Interstitial Cystitis Drugs Market - Key Players

Major players operating in the global interstitial cystitis drugs market include AbbVie Inc., Hyloris Pharmaceuticals SA, TAGCyx Biotechnologies, KYORIN Pharmaceutical Co., Ltd., PureTech Health, Vaneltix, Red Leaf Medical Inc., Bayer AG, Eli Lilly and Co, Johnson & Johnson (Janssen Pharmaceuticals), Mylan NV (Viatris Inc.), Perrigo Co. Plc, Pfizer Inc., Seikagaku Corp., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd. and ImprimisRx (Harrow Health, Inc.)

Interstitial Cystitis Drugs Market Report Snapshots